Operating Profit 更改
Acadia Pharmaceuticals USD 34.94M 92.72M 2023-12
Agios Pharmaceuticals USD -106277000 5.38M 2023-12
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
Amgen USD 1.27B 819M 2023-12
Avrobio USD -22933000 90.94M 2023-09
BioCryst Pharmaceuticals USD -11921000 37.8M 2023-09
Biogen USD 358.9M 200.1M 2023-12
BioMarin Pharmaceutical USD 14.22M 11.44M 2023-12
Bluebird Bio USD -84729000 568K 2023-09
Capricor Therapeutics USD -6865000 882K 2023-09
Daiichi Sankyo JPY 51.03B 7B 2023-09
Eli Lilly USD 2.39B 1.94B 2023-12
Esperion Therapeutics USD -27533000 9.52M 2023-09
Gilead Sciences USD 1.61B 1.01B 2023-12
Incyte USD 187.27M 27.44M 2023-12
Insmed USD -178272000 30.6M 2023-12
Ionis Pharmaceuticals USD 20.68M 166.04M 2023-12
Lumos Pharma USD -8932000 711K 2023-09
Moderna USD 6M 2.02B 2023-12
Nektar Therapeutics USD -44864000 5.74M 2023-09
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Novavax USD -125632000 181.09M 2023-09
Pfizer USD -6551000000 3.61B 2023-12
PTC Therapeutics USD -131738000 13.57M 2023-12
Regeneron Pharmaceuticals USD 972.9M 138.1M 2023-12
Roche Holding CHF 9.76B 3.84B 2023-06
Sarepta Therapeutics USD -48342000 16.82M 2023-09
Ultragenyx Pharmaceutical USD -122049000 23.05M 2023-12
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



Sarepta Therapeutics 营业利润 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.